Causal Effect of Genetic Variants Associated with Body Mass Index on Multiple Sclerosis Susceptibility

American Journal of Epidemiology

Volumn 185, Issue 3, 2017, Pages 162-171

  Gianfrancesco, Milena A ^a   Glymour, M Maria ^b   Walter, Stefan ^b   Rhead, Brooke ^a   Shao, Xiaorong ^a   Shen, Ling ^c   Quach, Hong ^a   Hubbard, Alan ^a   Jónsdóttir, Ingileif ^d   Stefánsson, Kári ^d   Strid, Pernilla ^e   Hillert, Jan ^f   Hedström, Anna ^f   Olsson, Tomas ^f   Kockum, Ingrid ^f   Schaefer, Catherine ^c,g   Alfredsson, Lars ^e,h   Barcellos, Lisa F ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d DECODE GENETICS   (Iceland)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g KAISER PERMANENTE   (United States)

^h NONE

Author keywords

body mass index; genetic instrumental variables; Mendelian randomization; multiple sclerosis; obesity

Indexed keywords

BODY MASS; DATA ASSIMILATION; ENVIRONMENTAL RISK; GENETIC VARIATION; HEALTH RISK; IMMUNE RESPONSE; NERVOUS SYSTEM DISORDER; OBESITY;

ARTICLE; BODY MASS; CALIFORNIA; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MULTIPLE SCLEROSIS; SMOKING; SWEDEN; ADULT; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED;

SWEDEN;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 85020853274     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kww120     Document Type: Article

References (42)

1. Su KG, Banker G, Bourdette D, et al. Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis. Curr Neurol Neurosci Rep. 2009;9(5):411-417.
2. Favorova OO, Kulakova OG, Boiko AN. Multiple sclerosis as a polygenic disease: An update [in Russian]. Genetika. 2010;46(3):302-313.
3. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15(18):2813-2824.
4. Beecham AH, Patsopoulos NA, Xifara DK, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353-1360.
5. Ascherio A, Munger K. Epidemiology of multiple sclerosis: From risk factors to prevention. Semin Neurol. 2008;28(1): 17-28.
6. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009;73(19): 1543-1550.
7. Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012; 18(9):1334-1336.
8. Gianfrancesco MA, Acuna B, Shen L, et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obes Res Clin Pract. 2014;8(5): E435-e447.
9. Wesnes K, Riise T, Casetta I, et al. Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study. Mult Scler. 2015;21(4):388-395.
10. Langer-Gould A, Brara SM, Beaber BE, et al. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 2013;80(6):548-552.
11. Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: A long-term cohort study. Mult Scler. 2013;19(10):1323-1329.
12. Hedstrom AK, Lima Bomfim I, Barcellos L, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014;82(10):865-872.
13. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.
14. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121-127.
16. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol. 2011;69(2):292-302.
17. Kvale MN, Hesselson S, Hoffmann TJ, et al. Genotyping informatics and quality control for 100, 000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. Genetics. 2015;200(4):1051-1060.
18. Glymour MM, Tchetgen Tchetgen EJ, Robins JM. Credible Mendelian randomization studies: Approaches for evaluating the instrumental variable assumptions. Am J Epidemiol. 2012; 175(4):332-339.
19. Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: Theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137-150.
20. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3(7): E115.
21. Loos RJ, Bouchard C. FTO: The first gene contributing to common forms of human obesity. Obes Rev. 2008;9(3): 246-250.
22. Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52.
23. Lewis SJ, Murad A, Chen L, et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One. 2010;5(10):e13485.
24. Lurie G, Gaudet MM, Spurdle AB, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One. 2011;6(2):e16756.
25. Keller L, Xu W, Wang HX, et al. The obesity related gene, FTO, interacts with APOE, is associated with Alzheimer's disease risk: A prospective cohort study. J Alzheimers Dis. 2011;23(3):461-469.
26. Ho AJ, Stein JL, Hua X, et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci USA. 2010;107(18):8404-8409.
27. Bressler J, Fornage M, Demerath EW, et al. Fat mass and obesity gene and cognitive decline: The Atherosclerosis Risk in Communities Study. Neurology. 2013;80(1):92-99.
28. Davis W, van Rensburg SJ, Cronje FJ, et al. The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors. Metab Brain Dis. 2014;29(2):409-419.
29. Belsky DW, Moffitt TE, Sugden K, et al. Development and evaluation of a genetic risk score for obesity. Biodemography Soc Biol. 2013;59(1):85-100.
30. Choh AC, Lee M, Kent JW, et al. Gene-by-age effects on BMI from birth to adulthood: The Fels Longitudinal Study. Obesity (Silver Spring). 2014;22(3):875-881.
31. Winer S, Paltser G, Chan Y, et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39(9):2629-2635.
32. Brown K, DeCoffe D, Molcan E, et al. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095-1119.
33. Manzel A, Muller DN, Hafler DA, et al. Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014;14(1):404.
34. Soskic S, Stokic E, Isenovic ER. The relationship between vitamin D and obesity. Curr Med Res Opin. 2014;30(6): 1197-1199.
35. Schoindre Y, Terrier B, Kahn JE, et al. Vitamin D and autoimmunity. First part: Fundamental aspects [in French]. Rev Med Interne. 2012;33(2):80-86.
36. Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47-59.
37. Fernandez-Rhodes L, Demerath EW, Cousminer DL, et al. Association of adiposity genetic variants with menarche timing in 92, 105 women of European descent. Am J Epidemiol. 2013;178(3):451-460.
38. Mao JH, Langley SA, Huang Y, et al. Identification of genetic factors that modify motor performance and body weight using Collaborative Cross mice. Sci Rep. 2015;5:16247.
39. Burgess S, Timpson NJ, Ebrahim S, et al. Mendelian randomization: Where are we now and where are we going Int J Epidemiol. 2015;44(2):379-388.
40. Barcellos LF, May SL, Ramsay PP, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 2009; 5(10):e1000696.
41. Li Y, Abecasis GR. Mach 1.0: Rapid haplotype reconstruction and missing genotype inference [abstract]. Am J Hum Genet. 2006;S79:2290.
42. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8): 904-909.